JP6867959B2 - 病院環境における感染の追跡 - Google Patents
病院環境における感染の追跡 Download PDFInfo
- Publication number
- JP6867959B2 JP6867959B2 JP2017566789A JP2017566789A JP6867959B2 JP 6867959 B2 JP6867959 B2 JP 6867959B2 JP 2017566789 A JP2017566789 A JP 2017566789A JP 2017566789 A JP2017566789 A JP 2017566789A JP 6867959 B2 JP6867959 B2 JP 6867959B2
- Authority
- JP
- Japan
- Prior art keywords
- samples
- sample
- infected
- over time
- changes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000015181 infectious disease Diseases 0.000 title claims description 81
- 238000000034 method Methods 0.000 claims description 39
- 230000000869 mutational effect Effects 0.000 claims description 17
- 238000012163 sequencing technique Methods 0.000 claims description 11
- 239000011159 matrix material Substances 0.000 claims description 10
- 244000052769 pathogen Species 0.000 claims description 10
- 238000012417 linear regression Methods 0.000 claims description 7
- 230000015654 memory Effects 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 5
- 230000002458 infectious effect Effects 0.000 claims description 4
- 238000012070 whole genome sequencing analysis Methods 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims 4
- 238000011017 operating method Methods 0.000 claims 3
- 239000012678 infectious agent Substances 0.000 claims 1
- 206010011409 Cross infection Diseases 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 101000588045 Homo sapiens Kunitz-type protease inhibitor 1 Proteins 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000008029 eradication Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 208000037041 Community-Acquired Infections Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physiology (AREA)
- Animal Behavior & Ethology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562191684P | 2015-07-13 | 2015-07-13 | |
| US62/191,684 | 2015-07-13 | ||
| PCT/IB2016/054139 WO2017009770A1 (en) | 2015-07-13 | 2016-07-11 | Tracking infections in hospital environments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018528503A JP2018528503A (ja) | 2018-09-27 |
| JP2018528503A5 JP2018528503A5 (enExample) | 2019-06-13 |
| JP6867959B2 true JP6867959B2 (ja) | 2021-05-12 |
Family
ID=56413716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566789A Active JP6867959B2 (ja) | 2015-07-13 | 2016-07-11 | 病院環境における感染の追跡 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10902936B2 (enExample) |
| EP (1) | EP3323069B1 (enExample) |
| JP (1) | JP6867959B2 (enExample) |
| CN (1) | CN107851135B (enExample) |
| BR (1) | BR112018000560A2 (enExample) |
| MX (1) | MX2018000171A (enExample) |
| RU (1) | RU2018105353A (enExample) |
| WO (1) | WO2017009770A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11961594B2 (en) * | 2019-06-28 | 2024-04-16 | Koninklijke Philips N.V. | System and method using clinical data to predict genetic relatedness for the efficient management and reduction of healthcare-associated infections |
| WO2021163223A1 (en) * | 2020-02-10 | 2021-08-19 | The Research Foundation For The State University Of New York | Using resilient systems inference for estimating hospital acquired infection prevention infrastructure performance |
| WO2021195594A1 (en) * | 2020-03-26 | 2021-09-30 | San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation | Compositions and methods for treating or ameliorating infections |
| WO2021233996A1 (en) * | 2020-05-19 | 2021-11-25 | Alacris Theranostics Gmbh | Method and system for fighting pandemic |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7349808B1 (en) * | 2000-09-06 | 2008-03-25 | Egenomics, Inc. | System and method for tracking and controlling infections |
| US6964850B2 (en) * | 2001-11-09 | 2005-11-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| EP2613278A2 (en) * | 2011-12-05 | 2013-07-10 | Koninklijke Philips Electronics N.V. | Retroactive extraction of clinically relevant information from patient sequencing data for clinical decision support |
| CN104010570B (zh) * | 2011-12-27 | 2016-08-24 | 皇家飞利浦有限公司 | 具有集成式过滤器的呼吸测量设备 |
| WO2014146096A1 (en) * | 2013-03-15 | 2014-09-18 | Egenomics, Inc. | System and method for determining relatedness |
-
2016
- 2016-07-11 JP JP2017566789A patent/JP6867959B2/ja active Active
- 2016-07-11 BR BR112018000560A patent/BR112018000560A2/pt not_active Application Discontinuation
- 2016-07-11 US US15/742,929 patent/US10902936B2/en active Active
- 2016-07-11 RU RU2018105353A patent/RU2018105353A/ru unknown
- 2016-07-11 MX MX2018000171A patent/MX2018000171A/es unknown
- 2016-07-11 CN CN201680041161.2A patent/CN107851135B/zh active Active
- 2016-07-11 WO PCT/IB2016/054139 patent/WO2017009770A1/en not_active Ceased
- 2016-07-11 EP EP16739265.3A patent/EP3323069B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10902936B2 (en) | 2021-01-26 |
| RU2018105353A3 (enExample) | 2020-02-03 |
| CN107851135B (zh) | 2022-03-01 |
| WO2017009770A1 (en) | 2017-01-19 |
| CN107851135A (zh) | 2018-03-27 |
| RU2018105353A (ru) | 2019-08-13 |
| US20190087535A1 (en) | 2019-03-21 |
| MX2018000171A (es) | 2018-03-26 |
| BR112018000560A2 (pt) | 2018-09-11 |
| EP3323069A1 (en) | 2018-05-23 |
| EP3323069B1 (en) | 2024-09-11 |
| JP2018528503A (ja) | 2018-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hetem et al. | Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus | |
| Williamson et al. | Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCC mec-IV as the dominant community-associated MRSA clone | |
| Venekamp et al. | Grommets (ventilation tubes) for recurrent acute otitis media in children | |
| JP6867959B2 (ja) | 病院環境における感染の追跡 | |
| Muller et al. | Hand hygiene compliance in an emergency department: the effect of crowding | |
| Fischer et al. | Is the readmission rate a valid quality indicator? A review of the evidence | |
| Donker et al. | Patient referral patterns and the spread of hospital-acquired infections through national health care networks | |
| Obolski et al. | Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae | |
| Sabat et al. | Complete-genome sequencing elucidates outbreak dynamics of CA-MRSA USA300 (ST8-spa t008) in an academic hospital of Paramaribo, Republic of Suriname | |
| Kohler et al. | Emergence of carbapenemase-producing Enterobacteriaceae, south-central Ontario, Canada | |
| Moualed et al. | Water precautions for prevention of infection in children with ventilation tubes (grommets) | |
| Gurieva et al. | Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus | |
| Jelley et al. | Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand | |
| Ross et al. | Implementation and operational research: a cost-effective, clinically actionable strategy for targeting HIV preexposure prophylaxis to high-risk men who have sex with men | |
| Micek et al. | Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert | |
| Garcia-Gutiérrez et al. | Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 | |
| Diao et al. | Orientation of DNA minicircles balances density and topological complexity in kinetoplast DNA | |
| Van Boven et al. | Detecting emerging transmissibility of avian influenza virus in human households | |
| Stalfors et al. | National assessment of validity of coding of acute mastoiditis: a standardised reassessment of 1966 records | |
| Schønheyder et al. | Placing the burden of bacteraemia in perspective | |
| Pawlowicz et al. | Implementation of an evidence-based algorithm reduces blood culture overuse in an adult emergency department | |
| Deepashree et al. | Implementation of active surveillance system to track hospital-acquired infections in a tertiary care hospital in India | |
| Senghore et al. | Inferring bacterial transmission dynamics using deep sequencing genomic surveillance data | |
| Harrison et al. | Automated sepsis detection, alert, and clinical decision support: act on it or silence the alarm? | |
| Xia et al. | Effects of incomplete inter-hospital network data on the assessment of transmission dynamics of hospital-acquired infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190509 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190509 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200929 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210323 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210409 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6867959 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |